Osteopathische Überlegungen zur Begleitung der Therapie des Mammakarzinoms

Anja Engel-Schulmeyer

doi:10.1055/a-1346-4567

DO - Deutsche Zeitschrift für Osteopathie, Table of Contents

DO - Deutsche Zeitschrift für Osteopathie 2021; 19(04): 4-10
DOI: 10.1055/a-1346-4567

Praxis

Mammakarzinom

Osteopathische Überlegungen zur Begleitung der Therapie des Mammakarzinoms

Anja Engel-Schulmeyer

Abstract

Die allopathische Therapie beim Mammakarzinom teilt sich in 3 Phasen: neoadjuvante Chemotherapie (zur präoperativen Tumorreduktion), Mastektomie und Radiotherapie. Phasenübergreifend kommt zusätzlich eine Hormontherapie zur Anwendung. Die Medikation bzw. das Therapieverfahren erzeugt in jeder Phase spezifische Beschwerden. Für diese werden osteopathische Behandlungsansätze unter Berücksichtigung bereits vorliegender Evidenz beschrieben.

Full Text

References

Literatur
1 Schem C, Jonat W, Maass N. Maligne Tumoren der Mamma. In: Petru E, Fink D, Köchli R, Loibl S. Praxisbuch Gynäkologische Onkologie. Berlin: Springer; 2019
2 Krawczyk N, Banys-Paluchowski M, Fehm T. Triple-negatives Mammakarzinom – neue Behandlungsstrategien. Der Gynäkologe 2020; 53: 771-779
3 de Groot S, Pijl H, van der Hoeven JJM. et al. Effects of short-term fasting on cancer treatment. J Exp Clin Cancer Res 2019; 38: 209
4 Sremanakova J, Sowerbutts AM, Burden S. A systematic review of the use of ketogenic diets in adult patients with cancer. J Hum Nutr Diet 2018; 31 (06) 793-802
5 Caccialanza R, Cereda E, De Lorenzo F. et al. To fast, or not to fast before chemotherapy, that is the question. BMC Cancer 2018; 18: 337
6 OʼFlanagan CH, Smith LA, McDonell SB. et al. When less may be more: calorie restriction and response to cancer therapy. BMC Med 2017; 15 (01) 106
7 http://www.cancer.org/treatment/treatments-and-side-effects/treatment-types/chemotherapy/chemotherapy-safety.htm Stand: 1.6.2021
8 Yuki M, Sekine S, Takase K. et al. Exposure of family members to antineoplastic drugs via excreta of treated cancer patients. J Oncol Pharm Pract 2013; 19 (03) 208-217
9 Speece CA, Crow WT, Simmons SL. Osteopathische Körpertechniken nach W.G. Sutherland: Ligamentous Articular Strain. Stuttgart: MVS; 2003
10 Buekens J. Bone – The best kept secret. School of Bones; 2020
11 Billhult A, Bergbom I, Stener-Victorin E. Massage relieves nausea in women with breast cancer who are undergoing chemotherapy. Journal of alternative and complementary medicine 2007; 13 (01) 53-57
12 Dibble SL, Chapman J, Mack KA. et al. Acupressure for nausea: results of a pilot study. Oncol Nurs Forum 2000; 27 (01) 41-47
13 Favier N, Guinet A, Nageleisen M. et al. Secondary effects and quality of life with chemotherapy: assessing the impact of an osteopathic treatment (multicentric randomized clinical trial). Russian Osteopathic Journal 2020; 3 – 4: 174-185
14 Lagrange A, Decoux D, Briot N. et al. Visceral osteopathic manipulative treatment reduces patient reported digestive toxicities induced by adjuvant chemotherapy in breast cancer: A randomized controlled clinical study. European Journal of Obstetrics & Gynecology and Reproductive Biology 2019; 241: 49-55
15 Chvetzoff G, Berthier A, Blanc E. et al. Osteopathy for chronic pain after breast cancer surgery: A monocentric randomised study. Bull Cancer 2019; 106 (05) 436-446
16 Goyal M, Goyal K, Narkeesh K. et al. Osteopathic manipulative treatment for post mastectomy lymphedema: A case report. International Journal of Osteopathic Medicine 2017; 26: 49-52
17 Sphar BG, Bowe C, Dains JE. The Impact of Peripheral Cooling on Chemotherapy-Induced Peripheral Neuropathy: An Integrative Review. J Adv Pract Oncol 2020; 11 (08) 845-857
18 Schaffler-Schaden D, Sassmann R, Johansson T. et al. Comparison of high tone therapy and transcutaneous electrical nerve stimulation therapy in chemotherapy-induced polyneuropathy. Medicine 2020; 99 (19) e20149
19 http://www.leitlinienprogramm-onkologie.de/leitlinien/mammakarzinom/ Stand: 1.6.2021
20 Moskovitz AH, Anderson BO, Yeung RS. et al. Axillary web syndrome after axillary dissection. Am J Surg 2001; 181 (05) 434-439
21 Ryans K. Incidence and predictors of axillary web syndrome and its association with lymphedema in women following breast cancer treatment: a retrospective study. Support Care Cancer 2020; 28 (12) 5881-5888
22 Yeung WM, McPhail SM, Kuys SS. A systematic review of axillary web syndrome (AWS). J Cancer Surviv 2015; 9 (04) 576-598
23 De Groef A, Van Kampen M, Dieltjens E. et al. Effectiveness of postoperative physical therapy for upper-limb impairments after breast cancer treatment: a systematic review. Arch Phys Med Rehabil 2015; 96 (06) 1140-1153
24 McNeely ML, Campbell K, Ospina M. et al. Exercise interventions for upper-limb dysfunction due to breast cancer treatment. Cochrane Database Syst Rev 2010; (06) CD005211
25 Meert GF. Das venöse und lymphatische System aus osteopathischer Sicht: Thorax, Abdomen, Becken, Extremitäten. München: Elsevier; 2007
26 Standley PR, Meltzer K. In vitro modeling of repetitive motion strain and manual medicine treatments: potential roles for pro- and anti-inflammatory cytokines. J Bodyw Mov Ther 2008; 12 (03) 201-203
27 Bordoni B, Zanier E. Understanding Fibroblasts in Order to Comprehend the Osteopathic Treatment of the Fascia. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556860/ Stand: 1.6.2021
28 Cowman MK, Schmidt TA, Raghavan P. et al. Viscoelastic Properties of Hyaluronan in Physiological Conditions. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4648226/ Stand: 1.6.2021
29 Fourie WJ, Robb KA. Physiotherapy management of axillary web syndrome following breast cancer treatment: Discussing the use of soft tissue techniques. Physiotherapy 2009; 95 (04) 314-320
30 Lederman E. Harmonische Techniken: Rhythmische Behandlung in der Osteopathie. München: Elsevier; 2006
31 Williams PE. Effect of intermittent stretch on immobilised muscle. Annals of the Rheumatic Diseases 1988; 47 (12) 1014-1016
32 Geller BM, Vacek PM, OʼBrien P. et al. Factors Associated with Arm Swelling after Breast Cancer Surgery. Journal of Womenʼs Health 2003; 12 (09) 921-930
33 Burkhart SS, Morgan CD, Kibler WB. The disabled throwing shoulder: Spectrum of Pathology Part II: Evaluation and treatment of SLAP lesions in throwers. Arthroscopy: The Journal of Arthroscopic & Related Surgery 2003; 19 (05) 531-539
34 Hinrichs CS, Watroba NL, Rezaishiraz H. et al. Lymphedema secondary to postmastectomy radiation: incidence and risk factors. Ann Surg Oncol 2004; 11 (06) 573-580
35 Miller CL, Specht MC, Skolny MN. et al. Risk of lymphedema after mastectomy: potential benefit of applying ACOSOG Z0011 protocol to mastectomy patients. Breast Cancer Res Treat 2014; 144 (01) 71-77
36 Ozaslan C, Kuru B. Lymphedema after treatment of breast cancer. Am J Surg 2004; 187 (01) 69-72
37 Petrek J, Senie R, Peters M. et al. Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis. Cancer 2001; 92: 1368-1377
38 Querci della Rovere G, Ahmad I, Singh P. et al. An audit of the incidence of arm lymphoedema after prophylactic level I/II axillary dissection without division of the pectoralis minor muscle. Ann R Coll Surg Engl 2003; 85 (03) 158-161
39 Werner RS, McCormick B, Petrek J. et al. Arm edema in conservatively managed breast cancer: obesity is a major predictive factor. Radiology 1991; 180 (01) 177-184
40 Godette K, Mondry TE, Johnstone PAS. Can manual treatment of lymphedema promote metastasis?. J Soc Integr Oncol 2006; 4 (01) 8-12
41 Ota KS. Postmastectomy lymphedema: a call for osteopathic medical research. J Am Osteopath Assoc 2006; 106 (03) 110-111
42 Hull MM. Lymphedema in women treated for breast cancer. Semin Oncol Nurs 2000; 16 (03) 226-237
43 Stecco C. Atlas des menschlichen Fasziensystems. München: Elsevier; 2016
44 Bagheri S, Ohlin K, Olsson G. et al. Tissue tonometry before and after liposuction of arm lymphedema following breast cancer. Lymphat Res Biol 2005; 3 (02) 66-80
45 Ezzo J, Manheimer E, McNeely ML. et al. Manual lymphatic drainage for lymphedema following breast cancer treatment. Cochrane Database Syst Rev 2015; (05) CD003475
46 Vereecken P, Mathieu A, Laporte M. et al. Spread of melanoma after lymphatic drainage: relaunching the debate. Int J Clin Pract 2003; 57 (05) 444-445
47 Opipari M, Perotta A, Essig-Beatty D. Oncology. In: Foundations of Osteopathic Medicine. 2. Aufl.. Philadelphia: Lippincott, Williams & Wilkins; 2003
48 Bergmann A, Baiocchi JMT, Rizzi SKL de A. et al. Drenagem Linfática Manual em Pacientes Oncológicos: Quais as Evidências Científicas e as Recomendações Clínicas?. Rev Bras Cancerol 2021; 67 (01) e-131055
49 de Vries D, Piller N, Dawson R. et al. Is there a link between LE treatment and breast cancer reoccurence?. Journal of Lymphoedema 2011; 2: 85-86
50 Flor EM, Flor EM, Flor AM. Manual lymph drainage in patients with tumoral activity. Journal of Phlebology and Lymphology 2009; 2: 13-15
51 Hsiao P-C, Liu J-T, Lin C-L. et al. Risk of breast cancer recurrence in patients receiving manual lymphatic drainage: a hospital-based cohort study. Ther Clin Risk Manag 2015; 11: 349-358
52 Ruiter DJ, van Krieken JH, van Muijen GN. et al. Tumour metastasis: is tissue an issue?. The Lancet Oncology 2001; 2 (02) 109-112
53 Kuchera M. Lymphatic approach. In: Chila AG. Foundations of osteopathic medicine. Philadelphia: Wolters Kluwer Health/Lippincott, Williams & Wilkins; 2011
54 Zink J, Lawson W. The role of pectoral traction in the treatment of lymphatic flow disturbances. Osteopath Annals 1978; 6 (11) 493e6
55 Hodge LM, Downey HF. Lymphatic pump treatment enhances the lymphatic and immune systems. Exp Biol Med 2011; 236 (10) 1109-1115
56 Knott EM, Oms V, Tune J. et al. Increased Lymphatic Flow in the Thoracic Duct During Manipulative Intervention. The Journal of the American Osteopathic Association 2005; 105 (10) 447-456
57 Olszewski WL. Contractility Patterns of Human Leg Lymphatics in Various Stages of Obstructive Lymphedema. Annals of the New York Academy of Sciences 2008; 1131 (01) 110-118
58 Paepke D. Integrative Medizin in der gynäkologischen Onkologie. Gynäkologe 2021; 54 (01) 5-9